$68.10 -0.24 (%) Endo International plc - NASDAQ

Oct. 1, 2014 | 04:00 PM

Partner Headlines

  1. Auxilium: Endo bid is too low

    IBD | Sep. 22, 2014 | 18:47PM EST
  2. Auxilium Says Endo Takeover Offer Undervalues Company

    IBD | Sep. 22, 2014 | 16:38PM EST
  3. US Stock Futures Decline Ahead Of Home Sales Report

    Benzinga | Sep. 22, 2014 | 07:38AM EST
  4. Auxilium may fight Endo bid

    IBD | Sep. 17, 2014 | 19:23PM EST
  5. Auxilium Mulls Endo Bid; Is $2.2 Billion Enough?

    IBD | Sep. 17, 2014 | 18:07PM EST
  6. Stocks Gain On Federal Reserve Update

    Benzinga | Sep. 17, 2014 | 16:50PM EST
  7. U.S. Stocks Gain After Fed Statement; General Mills Shares Fall On Downbeat Results

    Benzinga | Sep. 17, 2014 | 15:29PM EST
  8. Lennar Gains On Upbeat Earnings; Adobe Shares Slide

    Benzinga | Sep. 17, 2014 | 12:37PM EST
  9. Auxilium Mulls Endo Bid; Street Eyes A Higher Price

    IBD | Sep. 17, 2014 | 11:47AM EST
  10. Markets Gain; FedEx Profit Beats Street View

    Benzinga | Sep. 17, 2014 | 11:14AM EST
  11. Top Performing Industries For September 17, 2014

    Benzinga | Sep. 17, 2014 | 10:27AM EST
  12. Benzinga's Volume Movers

    Benzinga | Sep. 17, 2014 | 10:17AM EST
  13. Morning Market Movers

    Benzinga | Sep. 17, 2014 | 09:38AM EST
  14. Benzinga's Top #PreMarket Gainers

    Benzinga | Sep. 17, 2014 | 08:08AM EST
  15. Stocks To Watch For September 17, 2014

    Benzinga | Sep. 17, 2014 | 04:08AM EST
  16. Benzinga's M&A Chatter for Tuesday September 16, 2014

    Benzinga | Sep. 16, 2014 | 19:29PM EST
  17. ENDO INT'L

    IBD | Sep. 16, 2014 | 18:49PM EST
  18. Auxilium Pharmaceuticals, Inc. Gets $2.2 Billion Unsolicited Bid

    Benzinga | Sep. 16, 2014 | 17:42PM EST
  19. UPDATE: Endo Offers to Buy Auxilium Pharma at $28.10/Share in Cash, Stock

    Benzinga | Sep. 16, 2014 | 16:48PM EST
  20. Benzinga's Top Initiations

    Benzinga | Sep. 2, 2014 | 09:16AM EST
  21. RBC Capital Initiates Endo Health At Outperform

    Benzinga | Sep. 2, 2014 | 07:42AM EST
  22. Endo's Paladin Labs Reports Canadian Introduction Of Veregen

    Benzinga | Jul. 16, 2014 | 07:40AM EST
  23. Stock Futures Sag Early Monday; King Digital Leans Higher

    IBD | Jul. 7, 2014 | 08:59AM EST
  24. Benzinga's M&A Chatter for Tuesday June 24, 2014

    Benzinga | Jun. 24, 2014 | 17:53PM EST
  25. Wells Fargo Initiates Coverage On The Pharmaceutical Space

    Benzinga | Jun. 11, 2014 | 11:36AM EST
  26. UPDATE: Morgan Stanley Upgrades Endo International PLC On Attractive Risk-Reward

    Benzinga | May. 2, 2014 | 10:14AM EST
  27. Endo profit tops despite charge

    IBD | May. 1, 2014 | 18:51PM EST
  28. Sterne Agee Sees Good Things Ahead for Endo International PLC

    Benzinga | May. 1, 2014 | 08:10AM EST
  29. Earnings Scheduled For May 1, 2014

    Benzinga | May. 1, 2014 | 05:36AM EST
  30. Actavis Beats Q1 Views, Looks To Supersized Future

    IBD | Apr. 30, 2014 | 17:28PM EST
  31. Endo Reaches $830M Settlement on Majority of AMS Litigation Cases

    Benzinga | Apr. 30, 2014 | 16:32PM EST
  32. Actavis Q1 Earnings Beat On Generic Cymbalta Surprise

    IBD | Apr. 30, 2014 | 11:10AM EST
  33. Endo to Acquire Grupo Farmaceutico, No Terms Disclosed

    Benzinga | Apr. 29, 2014 | 08:32AM EST
  34. Morning Market Movers

    Benzinga | Apr. 24, 2014 | 09:42AM EST
  35. Benzinga's Top #PreMarket Gainers

    Benzinga | Apr. 24, 2014 | 08:11AM EST
  36. Zogenix Announces Sale of SUMAVEL DosePro Migraine Therapy to Endo International for $85M, Up to $20M Milestone Payments

    Benzinga | Apr. 24, 2014 | 07:31AM EST
  37. Forest Laboratories Is an Option for Wealthy Investors Who Could Afford to Pay a High Premium

    GuruFocus | Apr. 23, 2014 | 16:46PM EST
  38. Mylan Says Judge Has Enforced Settlement Deal Between Mylan, Endo Related to Generic FROVA

    Benzinga | Apr. 11, 2014 | 07:31AM EST
  39. Morgan Stanley Sees Possible Upside Source for Endo International PLC

    Benzinga | Apr. 10, 2014 | 09:58AM EST
  40. Ampio Pharmaceuticals' Vyrix Enters into an Agreement with Paladin Labs for Exclusive Rights to Zertane in Canada

    Benzinga | Apr. 10, 2014 | 08:05AM EST
  41. Meda Rejects Mylan's Bid

    IBD | Apr. 4, 2014 | 18:46PM EST
  42. Mylan Rejected In Bid To Acquire Sweden's Meda

    IBD | Apr. 4, 2014 | 12:27PM EST
  43. Market Wrap For March 6: Investors Find Positives In Jobless Claims

    Benzinga | Mar. 6, 2014 | 17:06PM EST
  44. Morgan Stanley Updates Estimates On Endo Health Solutions

    Benzinga | Mar. 3, 2014 | 10:07AM EST
  45. Market Wrap For February 28: Markets Unable To Hold On To Gains

    Benzinga | Feb. 28, 2014 | 16:53PM EST
  46. Earnings Scheduled For February 28, 2014

    Benzinga | Feb. 28, 2014 | 04:58AM EST
  47. Top 4 Mid-Cap Stocks In The Drug Manufacturers-Other Industry With The Lowest PEG Ratio

    Benzinga | Feb. 28, 2014 | 04:30AM EST
  48. Stocks End Higher; MercadoLibre Jumps After Hours

    IBD | Feb. 27, 2014 | 16:58PM EST
  49. Actavis Q4 Beats Street; Guidance Affirmed For Now

    IBD | Feb. 20, 2014 | 11:21AM EST
  50. Endo Confirms Court Upholds FROVA Patent

    Benzinga | Jan. 29, 2014 | 16:41PM EST
Trading Center